Breast cancer (BC) is one of the major public health challenges worldwide. Studies that address the new evidence on trends of BC are of great importance for preventing and controlling the occurrence and development of diseases and improving health. The a
The present study aimed at evaluating the global prevalence depression among patients with breast cancer.MethodsIn this meta-analysis, three electronic databases (PubMed, Web of Science, and Scopus) were searched from 1 January, 2000 until 30 March, 2019. The Hoy tool was used to evaluate the...
"Dramatic changes in lifestyle and built environment have had an impact on the prevalence of breast cancer risk factors such as excess body weight, physical inactivity, alcohol consumption, postponement of childbearing, fewer childbirths, and less breastfeeding," wrote the authors of the report...
The final mortality was divided by the estimated MIRs to calculate breast cancer incidence. Prevalence was divided into four different health states, including diagnosis or treatment, remission, metastatic, and terminal phase. Years lived with disability (YLDs) were estimated b...
Background: The burden of breast cancer has been increasing globally. The epidemiology burden and trends need to be updated. This study aimed to update the burden and trends of breast cancer incidences, deaths, and disability-adjusted life-years (DALYs) from 1990 to 2019, using the Global Bur...
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390...
Distribution of Cancer Deaths, Rates, and MIR in 2022 and Projected Deaths by 2050 Across Age, HDI, and Region View LargeDownload Supplement 1. eMethods. eTable 1. International Classification of Diseases, Tenth Revision (ICD-10), Codes for Cancers eTable 2. Cancer Prevalence in 2022 ...
It has been debated for several years as to whether the antidiabetic drug pioglitazone increases the risk for bladder cancer. A series of recent large population studies yielded conflicting results. To investigate why the observational studies yielded co
ACT supports the WHO Global Monitoring Framework on NCDs, which includes a voluntary target of a 30 percent reduction in prevalence of current tobacco use in people aged 15 and older by 2025. “Although the successes of the tobacco control measures are responsible for a reduction of the NCD bu...
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of ...